Minimally Invasive Glaucoma Surgery Devices
Minimally Invasive Glaucoma Surgery Devices Market by Device (Micro-Stents, Suprachoroidal Devices, Trabecular Meshwork Devices), Indication (Closed-Angle Glaucoma, Open-Angle Glaucoma), Surgery, End-User - Global Forecast 2024-2030
360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the minimally invasive glaucoma surgery devices market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[183 Pages Report] The Minimally Invasive Glaucoma Surgery Devices Market size was estimated at USD 501.35 million in 2023 and expected to reach USD 526.62 million in 2024, at a CAGR 5.35% to reach USD 722.55 million by 2030.

Minimally invasive glaucoma surgery (MIGS) devices represent a significant advancement in ophthalmology by offering safer, less invasive alternatives for reducing intraocular pressure in glaucoma patients. These devices, including trabecular micro-bypass stents, suprachoroidal shunts, and subconjunctival implants, effectively manage glaucoma by improving aqueous humor outflow. Minimally invasive glaucoma surgery (MIGS) devices are essential due to the rising incidence of glaucoma, which can lead to irreversible blindness. MIGS devices, used in outpatient surgeries and often combined with cataract procedures, provide quicker recovery and fewer complications. Primary users are hospitals, specialized eye clinics, and ambulatory surgery centers that benefit from reduced hospitalization times and enhanced safety. The rising geriatric population globally and increasing preference for minimally invasive surgery devices contribute to driving the market growth for minimally invasive glaucoma surgery devices. In addition, growing awareness about early glaucoma detection promotes the adoption of minimally invasive surgical devices. However, the high costs of minimally invasive glaucoma surgery devices, regulatory hurdles, and lengthy approval processes for introducing new glaucoma surgery devices pose significant challenges for market growth. Moreover, increasing investment in research and development for innovative and effective glaucoma surgery devices and advancements in telemedicine and remote patient monitoring present lucrative opportunities for market growth.

Regional Insights

In the Americas, particularly in the United States, the market for minimally invasive glaucoma surgery (MIGS) devices thrives due to a high glaucoma incidence, advanced healthcare infrastructure, and significant R&D investment facilitated by regulatory frameworks such as expedited FDA pathways. In Canada, growing demand is driven by an elderly population and supportive healthcare policies. Western European countries, including Germany, France, and the U.K., the adoption of MIGS is rising due to well-established systems and rising ophthalmology investments, while Eastern Europe is emerging with improvements in healthcare infrastructure. Middle Eastern countries, particularly the UAE and Saudi Arabia, invest heavily in healthcare advancements, bolstered by growth in medical tourism. Rapid growth in the Asia-Pacific region, comprising China, India, and Japan, highlights a focus on affordability and accessibility. With its significant population and rising glaucoma prevalence, China benefits from government investments in healthcare modernization, whereas Japan's advanced technology and aging population support strong MIGS market growth. In India, rising awareness and government health schemes drive adoption within the burgeoning healthcare sector. China's National Medical Products Administration (NMPA) is evolving to improve healthcare quality, with Japan's Pharmaceuticals and Medical Devices Agency (PMDA) advocating partnerships for smoother market entries. India is streamlining pathways despite complex bureaucracies, presenting significant market potential.

Minimally Invasive Glaucoma Surgery Devices Market
To learn more about this report, request a free PDF copy
Market Dynamics

The market dynamics represent an ever-changing landscape of the Minimally Invasive Glaucoma Surgery Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

  • Market Drivers
    • Increase in the preference for minimally invasive surgery devices
    • Rising geriatric population globally
    • Growing awareness about early glaucoma detection promoting the adoption of minimally invasive surgical devices
  • Market Restraints
    • High costs of minimally invasive glaucoma surgery devices
  • Market Opportunities
    • Increasing investment in research and development for innovative and effective glaucoma surgery devices
    • Advancements in telemedicine and remote patient monitoring
  • Market Challenges
    • Regulatory hurdles and long approval processes for introducing new glaucoma surgery devices
Market Segmentation Analysis
  • Device : Increasing preference for micro-stents for patients in the early-to-moderate stages of glaucoma

    The trabecular meshwork devices are engineered to enhance the drainage of aqueous humor through the eye's natural pathways, making them highly effective and safe for managing intraocular pressure (IOP). These devices are preferred for their minimally invasive approaches and compatibility with simultaneous surgical procedures, such as cataract surgery. Micro-stents represent another crucial segment within the MIGS landscape. These devices are inserted into the eye to facilitate the drainage of intraocular fluid, thereby reducing eye pressure. These devices are typically chosen for early-to-moderate stages of glaucoma, offering a balance of efficiency and patient comfort. Suprachoroidal devices provide an alternative drainage path for aqueous humor by channeling it into the suprachoroidal space. Though they are relatively new, these devices can potentially treat more complex cases of glaucoma. They are best suited for advanced cases or those unresponsive to other MIGS procedures, offering an alternative when traditional options fail. Viscocanalostomy devices increase fluid drainage by enlarging the canal of Schlemm, enhancing conventional outflow in the eye. These devices are gaining recognition for their minimally invasive approach and effectiveness. Although this device is in its early stages compared to other MIGS devices, ongoing innovation and clinical validation indicate promise. These devices are used for patients at higher risk of complications from traditional glaucoma surgeries, offering a safer, less invasive option with fewer postoperative issues.

  • End-user : Growing demand for minimally invasive glaucoma surgery (MIGS) devices in hospitals

    Hospitals play a critical role in adopting and using minimally invasive glaucoma surgery (MIGS) devices. These facilities possess the necessary infrastructure, advanced technology, and skilled professionals for complex surgical procedures. MIGS devices are favored for reducing recovery times, minimizing complications, and lowering infection risks compared to traditional glaucoma surgeries. Additionally, hospitals focus on preventive measures and sophisticated treatment options, accommodating a wide range of glaucoma patients. Ophthalmology clinics dedicated to specialized care for glaucoma patients increasingly adopt MIGS devices due to their less invasive nature. These clinics require reliable and straightforward devices, focusing on outpatient care and quick recovery. Devices must ensure minimal risk and high success rates. Ambulatory Surgical Centers (ASCs) are also significant in the MIGS devices market. Providing outpatient services, ASCs balance hospital-level care with efficient and swift procedures. They need MIGS devices that enable quick turnarounds and facilitate same-day discharge. The devices offer minimal hospital stay and cost-effectiveness.

Market Disruption Analysis

The market disruption analysis delves into the core elements associated with market-influencing changes, including breakthrough technological advancements that introduce novel features, integration capabilities, regulatory shifts that could drive or restrain market growth, and the emergence of innovative market players challenging traditional paradigms. This analysis facilitates a competitive advantage by preparing players in the Minimally Invasive Glaucoma Surgery Devices Market to pre-emptively adapt to these market-influencing changes, enhances risk management by early identification of threats, informs calculated investment decisions, and drives innovation toward areas with the highest demand in the Minimally Invasive Glaucoma Surgery Devices Market.

Porter’s Five Forces Analysis

The porter's five forces analysis offers a simple and powerful tool for understanding, identifying, and analyzing the position, situation, and power of the businesses in the Minimally Invasive Glaucoma Surgery Devices Market. This model is helpful for companies to understand the strength of their current competitive position and the position they are considering repositioning into. With a clear understanding of where power lies, businesses can take advantage of a situation of strength, improve weaknesses, and avoid taking wrong steps. The tool identifies whether new products, services, or companies have the potential to be profitable. In addition, it can be very informative when used to understand the balance of power in exceptional use cases.

Value Chain & Critical Path Analysis

The value chain of the Minimally Invasive Glaucoma Surgery Devices Market encompasses all intermediate value addition activities, including raw materials used, product inception, and final delivery, aiding in identifying competitive advantages and improvement areas. Critical path analysis of the <> market identifies task sequences crucial for timely project completion, aiding resource allocation and bottleneck identification. Value chain and critical path analysis methods optimize efficiency, improve quality, enhance competitiveness, and increase profitability. Value chain analysis targets production inefficiencies, and critical path analysis ensures project timeliness. These analyses facilitate businesses in making informed decisions, responding to market demands swiftly, and achieving sustainable growth by optimizing operations and maximizing resource utilization.

Pricing Analysis

The pricing analysis comprehensively evaluates how a product or service is priced within the Minimally Invasive Glaucoma Surgery Devices Market. This evaluation encompasses various factors that impact the price of a product, including production costs, competition, demand, customer value perception, and changing margins. An essential aspect of this analysis is understanding price elasticity, which measures how sensitive the market for a product is to its price change. It provides insight into competitive pricing strategies, enabling businesses to position their products advantageously in the Minimally Invasive Glaucoma Surgery Devices Market.

Technology Analysis

The technology analysis involves evaluating the current and emerging technologies relevant to a specific industry or market. This analysis includes breakthrough trends across the value chain that directly define the future course of long-term profitability and overall advancement in the Minimally Invasive Glaucoma Surgery Devices Market.

Patent Analysis

The patent analysis involves evaluating patent filing trends, assessing patent ownership, analyzing the legal status and compliance, and collecting competitive intelligence from patents within the Minimally Invasive Glaucoma Surgery Devices Market and its parent industry. Analyzing the ownership of patents, assessing their legal status, and interpreting the patents to gather insights into competitors' technology strategies assist businesses in strategizing and optimizing product positioning and investment decisions.

Trade Analysis

The trade analysis of the Minimally Invasive Glaucoma Surgery Devices Market explores the complex interplay of import and export activities, emphasizing the critical role played by key trading nations. This analysis identifies geographical discrepancies in trade flows, offering a deep insight into regional disparities to identify geographic areas suitable for market expansion. A detailed analysis of the regulatory landscape focuses on tariffs, taxes, and customs procedures that significantly determine international trade flows. This analysis is crucial for understanding the overarching legal framework that businesses must navigate.

Regulatory Framework Analysis

The regulatory framework analysis for the Minimally Invasive Glaucoma Surgery Devices Market is essential for ensuring legal compliance, managing risks, shaping business strategies, fostering innovation, protecting consumers, accessing markets, maintaining reputation, and managing stakeholder relations. Regulatory frameworks shape business strategies and expansion initiatives, guiding informed decision-making processes. Furthermore, this analysis uncovers avenues for innovation within existing regulations or by advocating for regulatory changes to foster innovation.

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Minimally Invasive Glaucoma Surgery Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Minimally Invasive Glaucoma Surgery Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • New World Medical Secures 510(k) Clearance for Expanded Kahook Dual Blade, Enhancing Glaucoma Treatment Options and Market Reach

    New World Medical Inc. had received 510k clearance for an expanded indication of its Kahook Dual Blade KDB Glide, leading to enhanced glaucoma treatment options. The regulatory approval allowed the company to target a broader patient population, potentially increasing the adoption of minimally invasive glaucoma surgery devices. The transaction involved New World Medical securing the necessary regulatory clearance, signifying a strategic milestone. [Published On: 2024-05-22]

  • OMNI Surgical System by Sight Sciences Shows Promising Results in Glaucoma Treatment, Anticipating Wider Adoption and Market Growth

    Sight Sciences Inc.'s OMNI Surgical System demonstrated a significant reduction in intraocular eye pressure in glaucoma patients, which generated increased interest and potential adoption in the eye care market. This result suggested a positive impact on patient outcomes and greater market penetration for minimally invasive glaucoma surgery devices. The transaction involved the anticipated use of the device in clinical settings based on these promising results the company expects widespread adoption among ophthalmologists and improved patient adherence to glaucoma treatment. [Published On: 2024-04-25]

  • iSTAR Medical SA Achieves CE Mark for Glaucoma Device, Eyes Expansion into U.S. Market

    iSTAR Medical SA's advancements in glaucoma treatment devices led to significant development in minimally invasive glaucoma surgery. The company acquired a CE mark for its new device facilitating entry into the European market, promising improvements in patient quality of life through less invasive procedures. This regulatory milestone increased investor interest and broadened market acceptance. [Published On: 2023-12-26]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Minimally Invasive Glaucoma Surgery Devices Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Minimally Invasive Glaucoma Surgery Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Medical Optics, Inc., Alcon Inc., Allergan PLC, Bausch & Lomb Inc., Carl-Zeiss AG, Corza Ophthalmology, Ellex Medical Lasers Ltd., Glaukos Corporation, InnFocus Inc., IOPtima, iSTAR Medical, Ivantis, Inc., Lumenis Be Ltd., Neomedix Corporation, New World Medical, Inc., Optonol Ltd., Santen Pharmaceutical Co., Ltd., Sight Sciences, Inc., and Topcon Corporation.

Minimally Invasive Glaucoma Surgery Devices Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Market Segmentation & Coverage

This research report categorizes the Minimally Invasive Glaucoma Surgery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Device
    • Micro-Stents
    • Suprachoroidal Devices
    • Trabecular Meshwork Devices
    • Viscocanalostomy Devices
  • Indication
    • Closed-Angle Glaucoma
    • Open-Angle Glaucoma
  • Surgery
    • Ab Externo
    • Ab Interno
  • End-User
    • Ambulatory Surgical Center
    • Hospital
    • Ophthalmology Clinic

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

This research report offers invaluable insights into various crucial aspects of the Minimally Invasive Glaucoma Surgery Devices Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Minimally Invasive Glaucoma Surgery Devices Market, by Device
  7. Minimally Invasive Glaucoma Surgery Devices Market, by Indication
  8. Minimally Invasive Glaucoma Surgery Devices Market, by Surgery
  9. Minimally Invasive Glaucoma Surgery Devices Market, by End-User
  10. Americas Minimally Invasive Glaucoma Surgery Devices Market
  11. Asia-Pacific Minimally Invasive Glaucoma Surgery Devices Market
  12. Europe, Middle East & Africa Minimally Invasive Glaucoma Surgery Devices Market
  13. Competitive Landscape
  14. Competitive Portfolio
  15. List of Figures [Total: 24]
  16. List of Tables [Total: 374]
  17. List of Companies Mentioned [Total: 19]
Frequently Asked Questions
  1. How big is the Minimally Invasive Glaucoma Surgery Devices Market?
    Ans. The Global Minimally Invasive Glaucoma Surgery Devices Market size was estimated at USD 501.35 million in 2023 and expected to reach USD 526.62 million in 2024.
  2. What is the Minimally Invasive Glaucoma Surgery Devices Market growth?
    Ans. The Global Minimally Invasive Glaucoma Surgery Devices Market to grow USD 722.55 million by 2030, at a CAGR of 5.35%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.